Search Articles

View query in Help articles search

Search Results (1 to 5 of 5 Results)

Download search results: CSV END BibTex RIS


Efficacy of Zemedy, a Mobile Digital Therapeutic for the Self-management of Irritable Bowel Syndrome: Crossover Randomized Controlled Trial

Efficacy of Zemedy, a Mobile Digital Therapeutic for the Self-management of Irritable Bowel Syndrome: Crossover Randomized Controlled Trial

IBS is highly prevalent, affecting up to 10% of the US population. Many studies have demonstrated that IBS has high rates of psychiatric comorbidity (up to 90% in treatment-seeking patients) [1,2], and causes social and occupational impairment [3]. Beyond the core symptoms of abdominal pain and altered bowel habits, individuals with IBS suffer from a host of related difficulties that substantially impair health-related quality of life (HRQL) and functioning.

Melissa G. Hunt, Sofia Miguez, Benji Dukas, Obinna Onwude, Sarah White

JMIR Mhealth Uhealth 2021;9(5):e26152